We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants

Delisted

COEPW was delisted on the 24th of April, 2026.

20 hedge funds and large institutions have $63.8K invested in Coeptis Therapeutics Warrants in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

12% more capital invested

Capital invested by funds: $56.9K → $63.8K (+$6.97K)

6.41% more ownership

Funds ownership: 0%6.41% (+6.4%)

5% more funds holding

Funds holding: 1920 (+1)

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

COEPW Hedge Fund Activity: Q1 2024 in Review

20 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2024, worth a combined $63.8K — up 12% from $56.9K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new COEPW positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Meteora Capital, adding an estimated $43K. The largest seller was Ionic Capital Management, cutting an estimated $17.4K.

  • 20 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2024, up from 19 in Q4 2023.
  • Funds reported $63.8K of Coeptis Therapeutics Warrants stock for Q1 2024, up 12% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2024 and 1 closed out, a net change of +1 holder.
  • The largest Coeptis Therapeutics Warrants buyer in Q1 2024 was Meteora Capital, an estimated $43K added.
  • The largest Coeptis Therapeutics Warrants seller in Q1 2024 was Ionic Capital Management, an estimated $17.4K sold.

Based on aggregated 13F filings for Q1 2024.